|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 31/00 | |
| A61P 31/06 | |||
| A61P 31/14 | |||
| A61P 33/02 | |||
| A61P 33/06 | |||
| A61P 35/00 | |||
| A61P 43/00 | |||
| A61K 39/00 | |||
| A61P 31/20 | |||
| C07K 16/28 |
| (11) | Patento numeris | 3153526 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16198909.0 |
| Europos patento paraiškos padavimo data | 2009-01-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 08300061 | 2008-01-31 | EP | |
| 08162683 | 2008-08-20 | EP |
| (72) |
LEVY, Yves, FR
ELIAOU, Jean-Franēois, FR
BENSUSSAN, Armand, FR
BONNEFOY-BERARD, Nathalie, FR
|
| (73) |
INSERM - Institut National de la Santé et de la Recherche Médicale,
101, rue de Tolbiac, 75013 Paris,
FR
|
| (54) | ANTIBODIES AGAINST HUMAN CD39 AND USE THEREOF FOR INHIBITING T REGULATORY CELLS ACTIVITY |
| ANTIBODIES AGAINST HUMAN CD39 AND USE THEREOF FOR INHIBITING T REGULATORY CELLS ACTIVITY |